When was Theramex founded?

Theramex was founded in 1970 and raised its 1st funding round 51 years after it was founded.

Where is Theramex located?

Theramex is headquartered in London, United Kingdom. It is registered at KANGA HEALTH LIMITED,1ST FLOOR, MEADOWSIDE,MOUNTBATTEN WAY,CONGLETON,CHESHIRE,UNITED KINGDOM,CW12 1DY.

How many employees does Theramex have?

As of Apr 30, 2026, the latest employee count at Theramex is 470.

Is Theramex a funded company?

Theramex is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Mar 01, 2021.

When was the latest funding round of Theramex?

Theramex's latest funding was a $***** Grant (prize money) round on Mar 01, 2021, with participation from 1 investor.

Where does Theramex rank among its competitors?

Theramex ranks 6th amongst 36 active competitors, of which 8 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Agile Therapeutics, which secured $275K in Feb, 2024.

Who are the top competitors of Theramex?

Theramex's top competitors include Agile Therapeutics, Prescient Therapeutics and Marius Pharmaceuticals. Among them, Agile Therapeutics secured the most recent funding round in February, 2024.

Theramex - 2026 Company Profile, Team, Funding, Competitors & Financials

Theramex is an acquired company based in London (United Kingdom), founded in 1970. It operates as a Manufacturer of drugs for women's health. Theramex has raised an undisclosed amount in funding. The company has 36 active competitors, including 8 funded and 12 that have exited. Its top competitors include companies like Agile Therapeutics, Prescient Therapeutics and Marius Pharmaceuticals.

Company Details

Theramex is a specialty pharmaceutical company offering drugs for women's health. They provide their products in the field of contraception, fertility, menopause, and osteoporosis.

Website: www.theramex.com/
Email ID: *****@theramex.com
Registered Address: KANGA HEALTH LIMITED,1ST FLOOR, MEADOWSIDE,MOUNTBATTEN WAY,CONGLETON,CHESHIRE,UNITED KINGDOM,CW12 1DY

Key Metrics

Founded Year

1970

Location

London, United Kingdom

Stage

Acquired

Latest Funding Round

Grant (prize money), Mar 01, 2021, $*****

Investors

Europa

Ranked

6^th among 36 active competitors

Employee Count

470 as on Apr 30, 2026

Similar Companies

Agile Therapeutics & 56 more

Exit Details

Acquired by PAI Partners (Mar 28, 2022)

View Theramex's full profile

Theramex is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
KANGA HEALTH LTD CIN: 8494015 , United Kingdom, Active	Apr 17, 2013	-	20 (As on Apr 30, 2024)

Theramex got acquired by PAI Partners and The Carlyle Group on Mar 28, 2022 at an acquisition amount of $*****.

Click here to take a look at Theramex's acquisition in detail

Theramex has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Mar 01, 2021 for $*****. 1 investor participated in its latest round. Theramex has 1 institutional investor.

Here is the list of recent funding rounds of Theramex:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 01, 2021	6864251	Grant (prize money)	1745475	4987164	7366088	5306606

Access funding benchmarks and valuations. Sign up today!

View details of Theramex's funding rounds and investors

Theramex's employee count trend

Theramex has 470 employees as of Apr 26. Here is Theramex's employee count trend over the years:

Uncover Theramex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Theramex include Agile Therapeutics, Prescient Therapeutics and Marius Pharmaceuticals. Here is the list of Top 10 competitors of Theramex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Agile Therapeutics 1997, Princeton (United States), Acquired	Developer of therapeutics for women healthcare	$124M	Aisling Capital, Kaiser Permanente Ventures ... & 11 others	57/100
2nd	Prescient Therapeutics 1986, South Melbourne (Australia), Public	Targeted small molecule inhibitors of Ras and Akt pathway for the treatment of cancer	$3M	-	51/100
3rd	Marius Pharmaceuticals 2017, Raleigh (United States), Series B	Developer of an proprietary oral testosterone replacement therapy platform	$32.6M	Shah Capital	49/100
4th	Peptonic Medical 2009, Vaxjo (Sweden), Public	Developer of therapeutics for the treatment of vaginal atrophy	$1.06M	Aggregate Media, Almi Invest & 1 others	46/100
5th	Auxilium Pharmaceuticals 1999, Philadelphia (United States), Acquired	Developer of therapeutics and drug-device combinations for urology and sexual health	$43M	Orbimed, Aisling Capital & 8 others	45/100
6th	Theramex 1970, London (United Kingdom), Acquired	Manufacturer of drugs for women's health	-	Europa	45/100
7th	Creative Medical Technologies 2011, Phoenix (United States), Public	Stem-cell based therapeutics for male and female reproductive health	-	-	43/100
8th	Bionovo 2002, Emeryville (United States), Public	Develops botanically-derived drugs for menopausal symptoms and cancer	$16.3M	Silicom Ventures, Centrecourt Asset Management ... & 1 others	42/100
9th	Microchips Biotech 1999, Lexington (United States), Acquired	Microchip-based implants for drug delivery	$90.7M	Medtronic, Polaris Partners & 8 others	42/100
10th	Asarina Pharma 2006, Umea (Sweden), Series A	Developer of drugs for the premenstrual dysphoric disorder (PMDD)	$28M	Idinvest Partners, Ergomed & 7 others	40/100